Immune-Mediated Damage and Repair

A03

Interplay between pro-inflammatory cytokines and chromatin-remodeling enzymes in the regulation of central nervous system demyelination and repair

Univ.-Prof. Dr. rer. nat. Ari Waisman
Institut für Molekulare Medizin
Mainz

Prof. Dr. rer. nat. Claire Jacob
Institut für Entwicklungsbiologie und Neurobiologie
Mainz

 

B05

Topological patterns of damage and compensation in chronic neuroinflammation

Prof. Dr. med. Sergiu Groppa
Klinik für Neurologie
Mainz

Prof. Dr.-Ing. Muthuraman Muthuraman
Klinik für Neurologie
Mainz

Univ.-Prof. Dr. med. Dr. rer. nat. Dr. h.c. Sven G. Meuth
Klinik für Neurologie
Düsseldorf

 

B06

The role of thr kallikrein-kinin system to functional and structural impairment if network activity in multiple sclerosis

Prof. Dr. rer. nat. Thomas Budde
Institut für Physiologie I
Münster

Dr. med. Kerstin Göbel
Klinik für Neurologie mit Institut für Translationale Neurologie
Münster

Univ.-Prof. Dr. med. Dr. rer. nat. Dr. h.c. Sven G. Meuth
Klinik für Neurologie
Düsseldorf

 

B07

Linking cholesterol metabolism in myeloid cells to remyelination in mice and humans

Univ.-Prof. Dr. med. Tanja Kuhlmann
Institut für Neuropathologie
Münster

Prof. Dr. med. Mikael Simons
Institut für Neuronale Zellbiologie
TU München

 

B09

Rebalancing cortical neuronal hyperactivity as a new treatment strategy in neuroinflammation

Dr. med. Erik Ellwardt
Klinik für Neurologie
Mainz

Univ.-Prof. Dr. med. Albrecht Stroh
Institut für Mikroskopische Anatomie und Neurobiologie
Mainz

 

B10

Molecular dissection of autoimmune lesion induction and resolution in the central nervous system

Univ.-Prof. Dr. med. Martin Kerschensteiner
Institut für Klinische Neuroimmunologie
LMU München

Priv.-Doz. Dr. rer. nat. Naoto Kawakami
Institut für Klinische Neuroimmunologie
LMU München

 

B12

Balancing glutamate and cation channel signaling in inflammatory neuronal injury

Prof. Dr. med. Stefan Bittner
Klinik für Neurologie
Mainz

 

B13

Disturbed iron metabolism in phagocytes as a driver of chronic inflammation – a model of MS progression?

Univ.-Prof. Dr. med. Mikael Simons
Institut für Neuronale Zellbiologie
TU München

Univ.-Prof. Dr. med. Martin Kerschensteiner
Institut für Klinische Neuroimmunologie
LMU München

 

B14

NfL and EGFL7 as biomarkers for neuroaxoonal damage and BBB-integrity in neuroinflammation: a translational approach

Dr. med. Timo Uphaus
Klinik für Neurologie
Mainz

Univ.-Prof. Dr. med. Frauke Zipp
Klinik für Neurologie, Forschungszentrum Immuntherapie
Mainz

News

Thu, 15/09/2022
Photo gallery: Inflammation & Imaging Symposium in the MIC building
Muenster. From September 12th to 14th scientists from Muenster University and their international guests discussed the latest developments in research on inflammation and the imaging of the immune system at the 2nd Inflammation & Imaging Symposium. The annual event is jointly organised by several research networks from Münster, among them the CRC/TRR 128 “Multiple Sclerosis”. […]...more
Tue, 28/06/2022
CRC Retreat in Münster
Muenster. After a long pause, more than 90 participants of the CRC joined in Muenster Factory Hotel to update on the latest developments. We heard the most recent on a selection of the CRC projects and there was also plenty of time for fruitful discussion and socializing in the evening....more
Mon, 23/05/2022
EU Research Council awards Lydia Sorokin Advanced Grant
Münster – The biochemist and Principal investigator of the CRC 128 Prof. Dr. Lydia Sorokin has received the coveted “Advanced Grant” awarded by the European Research Council (ERC). The funding of ca. 2.3 million euros enables the realisation of outstanding research projects. Lydia Sorokin heads the Institute for Physiological Chemistry and Pathobiochemistry at Muenster University. […]...more